124 related articles for article (PubMed ID: 37337403)
1. CYP1A inhibitors: Recent progress, current challenges, and future perspectives.
Dai Z; Wu Y; Xiong Y; Wu J; Wang M; Sun X; Ding X; Yang L; Sun X; Ge G
Med Res Rev; 2024 Jan; 44(1):169-234. PubMed ID: 37337403
[TBL] [Abstract][Full Text] [Related]
2. A Highly Selective Ratiometric Two-Photon Fluorescent Probe for Human Cytochrome P450 1A.
Dai ZR; Ge GB; Feng L; Ning J; Hu LH; Jin Q; Wang DD; Lv X; Dou TY; Cui JN; Yang L
J Am Chem Soc; 2015 Nov; 137(45):14488-95. PubMed ID: 26488456
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of cold-induced CYP1A activation in rat liver microsomes.
Perepechaeva M; Kolosova N; Grishanova A
J Physiol Biochem; 2011 Dec; 67(4):499-510. PubMed ID: 21505853
[TBL] [Abstract][Full Text] [Related]
4. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
Doostdar H; Burke MD; Mayer RT
Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cytochrome P450 1A (CYP1A) enzymes by monomethylmonothioarsonic acid (MMMTA
El-Ghiaty MA; Alqahtani MA; El-Kadi AOS
Chem Biol Interact; 2023 May; 376():110447. PubMed ID: 36893905
[TBL] [Abstract][Full Text] [Related]
6. Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.
Sridhar J; Goyal N; Liu J; Foroozesh M
Molecules; 2017 Jul; 22(7):. PubMed ID: 28698457
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 1A-dependent activities in deer, cattle and horses.
Darwish WS; Ikenaka Y; Eldaly EA; Ohno M; Sakamoto KQ; Fujita S; Ishizuka M
J Vet Med Sci; 2010 May; 72(5):561-6. PubMed ID: 20068271
[TBL] [Abstract][Full Text] [Related]
8. The Activation of Procarcinogens by CYP1A1/1B1 and Related Chemo-Preventive Agents: A Review.
Li Y; Cui J; Jia J
Curr Cancer Drug Targets; 2021; 21(1):21-54. PubMed ID: 33023449
[TBL] [Abstract][Full Text] [Related]
9. Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3,3',4,4'-tetrachlorobiphenyl: production of reactive oxygen by vertebrate CYP1As.
Schlezinger JJ; White RD; Stegeman JJ
Mol Pharmacol; 1999 Sep; 56(3):588-97. PubMed ID: 10462547
[TBL] [Abstract][Full Text] [Related]
10. Induction and suppression of cytochrome P450 1A by 3,3',4,4',5-pentachlorobiphenyl and its relationship to oxidative stress in the marine fish scup (Stenotomus chrysops).
Schlezinger JJ; Stegeman JJ
Aquat Toxicol; 2001 Apr; 52(2):101-15. PubMed ID: 11164533
[TBL] [Abstract][Full Text] [Related]
11. The dietary carcinogen PhIP activates p53-dependent DNA damage response in the colon of CYP1A-humanized mice.
Yang X; Peng H; Luo Z; Luo A; Cai M; Xu L; Wang H
Biofactors; 2021 Jul; 47(4):612-626. PubMed ID: 33811687
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of hepatic cytochromes P450 1A1 and 1A2 by arsenic trioxide (ATO) in vivo and in vitro: A role of heme oxygenase 1.
El-Ghiaty MA; Alqahtani MA; El-Kadi AOS
Chem Biol Interact; 2022 Sep; 364():110049. PubMed ID: 35872050
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals.
Iwata H; Yamaguchi K; Takeshita Y; Kubota A; Hirakawa S; Isobe T; Hirano M; Kim EY
Aquat Toxicol; 2015 May; 162():138-151. PubMed ID: 25814058
[TBL] [Abstract][Full Text] [Related]
14. Liver X receptor α bidirectionally transactivates human CYP1A1 and CYP1A2 through two cis-elements common to both genes.
Araki K; Watanabe K; Yamazoe Y; Yoshinari K
Toxicol Lett; 2012 Nov; 215(1):16-24. PubMed ID: 23041609
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide (ATO) up-regulates cytochrome P450 1A (CYP1A) enzymes in murine hepatoma Hepa-1c1c7 cell line.
El-Ghiaty MA; Alqahtani MA; El-Kadi AOS
Environ Toxicol Pharmacol; 2023 Aug; 101():104214. PubMed ID: 37423394
[TBL] [Abstract][Full Text] [Related]
16. Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes.
Yueh MF; Kawahara M; Raucy J
Toxicol In Vitro; 2005 Mar; 19(2):275-87. PubMed ID: 15649641
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study.
Juvonen RO; Jokinen EM; Javaid A; Lehtonen M; Raunio H; Pentikäinen OT
Chem Biol Drug Des; 2020 May; 95(5):520-533. PubMed ID: 32060993
[TBL] [Abstract][Full Text] [Related]
18. Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.
Arlt VM; Levová K; Bárta F; Shi Z; Evans JD; Frei E; Schmeiser HH; Nebert DW; Phillips DH; Stiborová M
Chem Res Toxicol; 2011 Oct; 24(10):1710-9. PubMed ID: 21932800
[TBL] [Abstract][Full Text] [Related]
19. Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes: CYP1A1 or CYP1A2?
Liu N; Zhang QY; Vakharia D; Dunbar D; Kaminsky LS
Arch Biochem Biophys; 2001 May; 389(1):130-4. PubMed ID: 11370663
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
